Latest News

On March 24, 2026, Oriental Land Co., Ltd. approved the establishment of wholly owned subsidiary ORIENTAL LAND CRUISE CO., LTD. to manage and operate Japan-based Disney cruise services, with operations planned to begin in Japanese fiscal year 2028. This move extends Oriental Land’s business beyond Tokyo Disney Resort®, aligning with its 2035 Long-term Management Strategy to build a more diversified leisure portfolio centered on cruise operations. With the new cruise subsidiary set to run...

Why Forestar Group is on investors’ radar today Forestar Group (FOR) has drawn fresh attention after a period where the share price showed mixed short term moves, including a 1 day gain alongside weaker returns over the month. For readers tracking real estate related names, the stock’s recent share performance and financial profile, including revenue of US$1,685.0 million and net income of US$166.8 million, raise questions about how the market is currently viewing its valuation. See our...

Ackermans & Van Haaren (ENXTBR:ACKB) has just wrapped up FY 2025 with second half revenue of €2.9b, basic EPS of €9.78 and trailing twelve month EPS of €18.14. This frames a year where earnings growth of 28.9% ran ahead of the five year EPS pace of 7.7% per year. Over the last twelve months, revenue has been described as growing at about 2.8% per year while the trailing net margin moved from 7.6% to 9.9%, so the latest half sits against a backdrop of firmer profitability. For investors, that...

Lamb Weston Holdings (LW) has put fresh numbers on the board for Q3 2026, with quarterly revenue of about US$1.6b and basic EPS of US$0.45, while the latest trailing twelve month figures show revenue of roughly US$6.5b and EPS of US$2.80. Over recent periods the company has seen quarterly revenue move between about US$1.52b and US$1.68b and basic EPS range from a loss of US$0.25 per share to US$1.03 per share, alongside trailing twelve month EPS running between roughly US$2.08 and US$2.80...

In recent weeks, Goldman Sachs Group has issued a broad range of new fixed-income securities across currencies and maturities while benefiting from Basel III revisions that reduce capital requirements for large banks, supporting its capacity to lend, underwrite and return capital. Analysts now see a stronger business outlook driven by expectations for increased mergers and acquisitions activity and deeper use of artificial intelligence across Goldman’s operations, which together could...

If you are wondering whether Republic Bancorp's current share price gives you good value, the starting point is understanding how that price lines up against a few different valuation yardsticks. The stock last closed at US$70.96, with returns of 3.2% over 7 days, 1.7% over 30 days, 4.3% year to date, 13.4% over 1 year, 89.0% over 3 years and 82.2% over 5 years, which gives useful context before comparing the price to value. Recent attention on Republic Bancorp has centered on its role in...

Commonwealth Bank of Australia (ASX:CBA) has moved into focus after lifting its inflation expectations in response to the Iran conflict, which has increased uncertainty around future Reserve Bank rate calls and upcoming domestic payment reforms. See our latest analysis for Commonwealth Bank of Australia. At a share price of A$171.9, CBA has logged a 7.06% 90 day share price return and a 14.25% 1 year total shareholder return. This points to momentum that remains broadly positive despite...

For readers wondering whether Illumina at around US$126.63 is priced for opportunity or already reflects the current story, this article walks through what the share price might be implying about value. The stock has had a mixed run, with a 0.3% return over 7 days and a 4.7% decline over 30 days, set against a 54.7% gain over the past year and longer term declines of 43.6% over 3 years and 67.5% over 5 years. These moves have come as Illumina remains in focus for investors, following ongoing...

Onward Medical (ENXTBR:ONWD) has reported its FY 2025 first half with revenue of €1.2 million, a basic EPS loss of €0.47, and net income loss of €21.2 million, setting a clear tone for another year focused on growth over profitability. The company has seen revenue move from €0.2 million in the first half of 2024 to €1.5 million in the second half of 2024 and €1.2 million in the first half of 2025. Basic EPS has shifted between losses of €0.53, €0.32, and €0.47 over the same periods,...

Insulet (PODD) recently disclosed a voluntary device correction for certain Omnipod 5 lots after 18 serious adverse events, including hospitalizations and diabetic ketoacidosis, while affirming its existing outlook and excluding remediation costs from non GAAP results. See our latest analysis for Insulet. The voluntary device correction and recent executive appointments come at a time of softer share performance, with a 30 day share price return of 15.65% and a 1 year total shareholder return...

Calliditas Therapeutics AB, an Asahi Kasei company, has recently announced that new Phase 3 NefIgArd study data in primary immunoglobulin A nephropathy (IgAN) will be presented at the 2026 World Congress of Nephrology in Yokohama, Japan, including secondary, biomarker, and mechanistic analyses of its gut-targeted therapy Nefecon. This extensive dataset, spanning seven scientific posters and a dedicated symposium on the evolving IgAN treatment paradigm, underscores Asahi Kasei’s growing...

Royal Caribbean Group and Bank of America recently launched the Royal ONE and Royal ONE Plus tri-branded Visa Signature credit cards, allowing guests to earn and redeem rewards across Royal Caribbean, Celebrity Cruises, and Silversea with tiered point multipliers and travel perks. The new cards deepen Royal Caribbean Group’s loyalty ecosystem by tying everyday spending to cruise savings and onboard credits, reinforcing its focus on higher-value, repeat guests. Next, we’ll explore how this...

Elon Musk publicly denied rumors that SoFi Technologies would be excluded from the upcoming SpaceX IPO. Musk confirmed that retail focused platforms like SoFi remain part of the plan for SpaceX share access. The clarification follows media speculation that raised questions about SoFi’s role in high profile IPO allocations. For investors watching SoFi Technologies (NasdaqGS:SOFI), Musk’s comments directly touch on one of the areas that sets the platform apart: access to sought after...

Crypto and blockchain stocks sit at the intersection of technology, finance, and changing market plumbing, which can be appealing when geopolitical tensions, energy prices, and bond yields keep shifting. With manufacturing data mixed across regions and input costs under pressure, many investors are looking beyond traditional sectors to themes tied to digital infrastructure and alternative transaction systems. Our Top Cryptocurrency and Blockchain Stocks screener filters this broad universe...

Ligand Pharmaceuticals (LGND) has been drawing attention after recent share performance data highlighted mixed short term returns alongside stronger longer term outcomes, prompting investors to reassess how its current pricing lines up with fundamentals. See our latest analysis for Ligand Pharmaceuticals. At a share price of $199.62, Ligand Pharmaceuticals has seen short term share price pressure, with a 7 day return of 2.41% and a 30 day return of 1.45%. Longer horizons show stronger...

JFB Construction Holdings (JFB) has just posted another tough set of numbers for FY 2025, with Q3 revenue of US$5.0 million and a basic EPS loss of US$0.05, set against a trailing 12 month revenue decline of 20.4% and no net profit over the period. The company has seen quarterly revenue move from US$7.1 million in Q4 2024 to US$5.9 million in Q1 2025, US$3.7 million in Q2 2025, and US$5.0 million in Q3 2025. EPS shifted from a modest profit of US$0.02 per share in Q4 2024 to small gains in Q1...

Arch Capital Group overview and recent share performance Arch Capital Group (ACGL) has attracted attention after recent price moves, with the stock down about 5.5% over the past month and roughly flat over the past 3 months. At a last close of US$95.49 and a market cap of about US$34.1b, the Bermuda based insurance and reinsurance group offers exposure across insurance, reinsurance and mortgage segments, each contributing meaningful revenue. See our latest analysis for Arch Capital...

IMAX stock performance snapshot IMAX (IMAX) is back on radar for some investors after recent share price moves, with the stock up about 1.7% over the past day but showing an 8.0% decline over the past month. That short term pullback sits alongside a 4.5% gain over the past 3 months and a 7.3% return year to date. This underlines how volatile shorter windows can look when you zoom in. See our latest analysis for IMAX. At a share price of $38.64, IMAX has paired a recent 8.0% one month share...

Charlotte's Web Holdings (TSX:CWEB) just posted its FY 2025 third quarter numbers, with revenue of US$11.5 million and a basic EPS loss of US$0.04, while the trailing twelve months show revenue of US$49.2 million and a basic EPS loss of US$0.14. Over recent quarters, revenue has held in a tight band around the low US$10 million range each period and EPS has consistently reflected losses. This gives a clear picture of a business that is still spending more than it earns. For investors, the...

What Ferrari (RACE) investors can glean from recent performance Ferrari (RACE) has drawn attention after a mixed run in the stock, with a 1 day gain of 1.18% and a 6.29% move over the past week, in contrast with weaker returns over the past month and past 3 months. See our latest analysis for Ferrari. At a share price of $342.43, Ferrari’s recent rebound, including the 7 day share price return of 6.29%, contrasts with a softer 30 day and year to date share price trend. The 1 year total...

Syensqo (ENXTBR:SYENS) has wrapped up FY 2025 with fourth quarter revenue of €1,384 million and basic EPS of a €1.61 loss, while the trailing twelve months show revenue of €5,969 million and basic EPS of a €0.85 loss. Over recent quarters, revenue has moved from €1,662 million in Q4 2024 to €1,678 million in Q1 2025, €1,639 million in Q2 2025, €1,558 million in Q3 2025, and €1,384 million in Q4 2025, with EPS swinging between a €1.28 loss and a €0.49 gain before landing at a €1.61 loss this...

NexPoint Real Estate Finance (NREF) just wrapped up FY 2025 with Q4 total revenue of US$30.0 million and basic EPS of US$0.67. Trailing twelve month revenue came in at US$157.3 million and EPS at US$4.28. Over the past year, the company has seen revenue move from US$73.1 million to US$157.3 million on a trailing basis, with EPS shifting from US$1.02 to US$4.28. This context allows investors to weigh these results against expectations. With margins running well ahead of the prior year, the...

Recent share performance context Anheuser-Busch InBev (ENXTBR:ABI) has seen mixed recent returns, with the stock up 1.7% over the past day and 1.6% over the past week, while showing a 9.7% decline over the past month. See our latest analysis for Anheuser-Busch InBev. At a share price of €60.74, Anheuser-Busch InBev has a positive year to date share price return of 11.65%, while the 1 year total shareholder return of 7.5% suggests momentum has cooled after a stronger recent quarter. If you are...

Considering whether Kyndryl Holdings is starting to look like value after a tough run, or if the current price still does not fully reflect the risks. The stock last closed at US$12.85, with returns of 1.6% over 7 days and 0.2% over 30 days, but a much softer picture year to date with a 49.6% decline and a 61.2% decline over 1 year. Recent coverage has focused on Kyndryl Holdings as a standalone IT services player following its separation from IBM. This has highlighted the challenge of...